Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis

Frontiers in Pharmacology(2021)10.3389/fphar.2021.637618Source: DataRank Database

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis is a research paper published in Frontiers in Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.60)OA: goldTopics (20)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Veronique de Jager ORCID,Elana van Brakel,Helmuth Reuter ORCID,Nikhil Gupte ORCID,Naadira Vanker ORCID

Live enrichment

PubMed:34267655 PMC:PMC8275874 OpenAlex:https://openalex.org/W3176608587

FDA HHS

Grant: R01 FD005724

NIAID NIH HHS

Grant: K24 AI150349

FWCI

0.60

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fphar.2021.637618/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2021.637618/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2021.637618/full

journalhttps://doi.org/10.3389/fphar.2021.637618

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34267655

Fields of Study

Antibiotics Pharmacokinetics and EfficacyPneumonia and Respiratory InfectionsTuberculosis Research and Epidemiology

Keywords

MeropenemPharmacokineticsMedicinePopulationVolume of distributionNONMEMRifampicinAntibacterial agentPharmacologyInternal medicineTuberculosisAntibioticsBiologyMicrobiologyPharmacokinetics AnalysisPopulation Pharmacokinetic (Pk) ModelDrug Sensitive Tb

Sustainable Development Goals

SDG 0: Good health and well-being